PIQRAY
Novartis AG
Application Filed: 2014-05-13
Trademark Application Details
ABANDONED - NO STATEMENT OF USE FILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 86279420 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Novartis Pharmaceuticals Corporation |
| Attorney Name | Maury M. Tepper, III |
| Law Office Assigned | M30 |
| Employee Name | TAYLOR, DAVID T |
Timeline
| 2014-05-13 | Application Filed |
| 2014-08-05 | Published for Opposition |
| 2015-09-28 | Location: INTENT TO USE SECTION |
| 2017-11-06 | Abandon |
| 2017-11-06 | Status: Dead/Abandoned |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Novartis AG |
| Address | CH-4002 Basel CH |
| Legal Entity Type | Corporation |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2014-05-16 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2014-05-23 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2014-06-30 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2014-06-30 | 4 CNSA P: |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2014-07-16 | 5 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2014-08-05 | 6 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2014-08-05 | 7 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2014-09-30 | 8 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2015-03-23 | 9 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2015-03-23 | 10 EXT1 S: |
| EXTENSION 1 GRANTED | 2015-03-23 | 11 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-03-25 | 12 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2015-09-21 | 13 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2015-09-28 | 14 AITU A:Allowance for Publication |
| EXTENSION 2 FILED | 2015-09-21 | 15 EXT2 S: |
| EXTENSION 2 GRANTED | 2015-09-29 | 16 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2015-09-30 | 17 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2016-03-24 | 18 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2016-04-28 | 19 AITU A:Allowance for Publication |
| EXTENSION 3 FILED | 2016-03-24 | 20 EXT3 S: |
| EXTENSION 3 GRANTED | 2016-04-28 | 21 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-04-29 | 22 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2016-09-21 | 23 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2016-09-21 | 24 EXT4 S: |
| EXTENSION 4 GRANTED | 2016-10-19 | 25 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2016-10-20 | 26 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2017-03-28 | 27 EEXT I:Incoming Correspondence |
| EXTENSION 5 FILED | 2017-03-28 | 28 EXT5 S: |
| EXTENSION 5 GRANTED | 2017-04-05 | 29 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2017-04-07 | 30 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2017-11-06 | 31 ABN6 S: |
| ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | 2017-11-06 | 32 MAB6 O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 PIQRAY 86279420 not registered Dead/Abandoned |
Novartis AG 2014-05-13 |
 PIQRAY 79219218 5415224 Live/Registered |
NOVARTIS AG 2017-08-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 